Final Results of a Phase II Prospective Trial Evaluating the Combination of Stereotactic Body Radiotherapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引:19
作者
Campbell, A. M. [1 ]
Cai, W. L. [1 ]
Burkhardt, D. [2 ]
Gettinger, S. N. [3 ]
Goldberg, S. B. [4 ]
Amodio, M. [2 ]
Kaech, S. [5 ]
Krishnaswamy, S. [2 ]
Decker, R. H. [6 ]
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA
[3] Yale Univ, Dept Med Oncol, New Haven, CT USA
[4] Yale Sch Med, Dept Med Oncol, New Haven, CT USA
[5] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT USA
[6] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词
D O I
10.1016/j.ijrobp.2019.06.453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
74
引用
收藏
页码:S36 / S37
页数:2
相关论文
empty
未找到相关数据